These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11927298)

  • 1. Clinical association with urinary glycosaminoglycans and urolithiasis.
    Erturk E; Kiernan M; Schoen SR
    Urology; 2002 Apr; 59(4):495-9. PubMed ID: 11927298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate.
    Ombra MN; Casula S; Biino G; Maestrale G; Cardia F; Melis P; Pirastu M
    Urology; 2003 Sep; 62(3):416-20. PubMed ID: 12946738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion of glycosaminoglycans in normal and stone forming subjects.
    Michelacci YM; Glashan RQ; Schor N
    Kidney Int; 1989 Dec; 36(6):1022-8. PubMed ID: 2601252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary glycosaminoglycan excretion in healthy and stone-forming children.
    Harangi F; Györke Z; Melegh B
    Pediatr Nephrol; 1996 Oct; 10(5):555-8. PubMed ID: 8897554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary glycosaminoglycan excretion in urolithiasis.
    Akçay T; Konukoğlu D; Dínçer Y
    Arch Dis Child; 1999 Mar; 80(3):271-2. PubMed ID: 10325710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excretion of urinary calcium and oxalate on three diets in patients with urolithiasis.
    Juuti M; Alhava EM
    Ann Clin Res; 1980 Dec; 12(6):320-5. PubMed ID: 7235608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The excretion of glycosaminoglycans in the urine of stone formers.
    Teotia M; Teotia SP; Singh DP; Nath M
    J Assoc Physicians India; 1988 Nov; 36(11):640-2. PubMed ID: 3248989
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of urinary stone disease and extracorporeal shockwave lithotripsy on excretion of glycosaminoglycans.
    Erkurt B; Ilker Y; Budak Y; Ozveren B; Türkeri L; Akdas A
    J Endourol; 1999 Oct; 13(8):553-7. PubMed ID: 10597124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of glycosaminoglycans for the formation of calcium oxalate stones.
    Hesse A; Wuzel H; Vahlensieck W
    Am J Kidney Dis; 1991 Apr; 17(4):414-9. PubMed ID: 2008909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial collection of an inadequate 24-hour urine sample in children does not predict subsequent inadequate collections.
    Chan KH; Moser EA; Whittam BM; Misseri R; Cain MP; Krambeck A; Schwaderer A
    J Pediatr Urol; 2019 Feb; 15(1):74.e1-74.e7. PubMed ID: 30467015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycans in urolithiasis.
    Nesse A; Garbossa G; Romero MC; Bogado CE; Zanchetta JR
    Nephron; 1992; 62(1):36-9. PubMed ID: 1436289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects.
    Ryall RL; Marshall VR
    Clin Chim Acta; 1984 Aug; 141(2-3):197-204. PubMed ID: 6488555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary glycosaminoglycans in normal subjects and patients with stones.
    Hwang TI; Preminger GM; Poindexter J; Pak CY
    J Urol; 1988 May; 139(5):995-7. PubMed ID: 3361677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary sulfated glycosaminoglycan insufficiency and chondroitin sulfate supplement in urolithiasis.
    Dissayabutra T; Kalpongnukul N; Chindaphan K; Srisa-Art M; Ungjaroenwathana W; Kaewwongse M; Iampenkhae K; Tosukhowong P
    PLoS One; 2019; 14(3):e0213180. PubMed ID: 30845174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons.
    Hesse A; Wuzel H; Vahlensieck W
    Urol Int; 1986; 41(2):81-7. PubMed ID: 3727195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary glycosaminoglycans after extracorporeal shock wave lithotripsy in patients with kidney lithiasis].
    Pérez-Blanco FJ; Arrabal Martín M; Ocete Martín C; Arias Puerta JJ; García-Valdecasas Bernal J; Rodríguez Cuartero A; Zuluaga Gómez A
    Arch Esp Urol; 2001 Nov; 54(9):875-83. PubMed ID: 11789367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary glycosaminoglycan excretion following extracorporeal shock wave lithotripsy.
    Alkibay T; Karabas O; Hizel N; Bozkirli I
    Int Urol Nephrol; 1993; 25(4):321-6. PubMed ID: 8276560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [2,8-dihydroxyadenine urolithiasis: case report and literature review].
    Arancio M; Ranzoni S; Delsignore A; Landi G; Maffei N; Marcato M; Mina A; Martinengo C
    Urologia; 2011; 78(4):305-9. PubMed ID: 21553389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of the calcium to creatinine concentration ratio of a single-voided urine specimen in patients with hypercalciuric urolithiasis.
    Matsushita K; Tanikawa K
    Tokai J Exp Clin Med; 1987 Sep; 12(3):167-71. PubMed ID: 3454077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.